{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:30:23Z","timestamp":1722493823980},"reference-count":37,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej14-0455","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T18:04:37Z","timestamp":1427652277000},"page":"441-447","source":"Crossref","is-referenced-by-count":5,"title":["Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor"],"prefix":"10.1507","volume":"62","author":[{"given":"Yoshihiro","family":"Sekiguchi","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetology, Ohme Municipal General Hospital, Ohme 198-0042, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetology, Ohme Municipal General Hospital, Ohme 198-0042, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Division of Pathology, Ohme Municipal General Hospital, Ohme 198-0042, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetology, Ohme Municipal General Hospital, Ohme 198-0042, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tani","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Kitasato University School of Medicine, Sagamihara 252-0374, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Doi","sequence":"additional","affiliation":[{"name":"Doi Medical Clinic, Kumamoto 861-5255, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hirata","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research and Innovation Hospital, Kobe 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet<\/i> 367: 1605-1617.","DOI":"10.1016\/S0140-6736(06)68699-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, et al. (2006) The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab<\/i> 91: 371-377.","DOI":"10.1210\/jc.2005-1542"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zemskova MS, Gundabolu B, Sinaii N, Chen CC, Carrasquillo JA, et al. (2010) Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab<\/i> 95: 1207-1219.","DOI":"10.1210\/jc.2009-2282"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Beuschlein F, Hammer GD (2002) Ectopic pro-opiomelanocortin syndrome. Endocrinol Metab Clin North Am<\/i> 31:191-234.","DOI":"10.1016\/S0889-8529(01)00025-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, et al. (2005) Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab<\/i> 90: 4955-4962.","DOI":"10.1210\/jc.2004-2527"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tani Y, Sugiyama T, Izumiyama H, Yoshimoto T, Yamada S, et al. (2011) Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors. Endocr J <\/i>58: 297-303.","DOI":"10.1507\/endocrj.K10E-389"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, et al. (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol <\/i>26: 3063-3072.","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koide Y, Inoue S, Murayama H, Kawai K, Yamashita K (1985) Effect of o,p’-DDD on cortisol metabolism in Cushing’s syndrome of various etiology. Endocrinol Jpn <\/i>32:615-624.","DOI":"10.1507\/endocrj1954.32.615"},{"key":"9","unstructured":"9. Hirano T, Otake H, Watanabe N, Oriuchi N, Zennyouji A, et al. (1995) Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG. J Nucl Med <\/i>36:2243-2245."},{"key":"10","unstructured":"10. Kimura N, Ishikawa T, Sasaki Y, Sasano N, Onodera K, et al. (1996) Expression of prohormone convertase, PC2, in adrenocorticotropin producing thymic carcinoid with elevated plasma corticotropin releasing hormone. J Clin Endocrinol Metab<\/i> 81: 390-395."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, et al. (1999) Thymic neuroendocrine tumor (thymic carcinoid):a clinicopathologic study in 15 patients. Ann Thorac Surg<\/i> 67:208-211.","DOI":"10.1016\/S0003-4975(98)01063-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ohta K, Shichiri M, Kameya T, Matsubara O, Imai T, et al. (2000) Thymic hyperplasia as a source of ectopic ACTH production. Endocr J <\/i>47: 487-492.","DOI":"10.1507\/endocrj.47.487"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takahashi T, Hatao K, Yamashita Y, Tanizawa Y (2003) Ectopic ACTH syndrome due to thymic atypical carcinoid treated with combination chemotherapy of cisplatin and etoposide. Intern Med <\/i>42:1197-1201.","DOI":"10.2169\/internalmedicine.42.1197"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yano M, Fukai I, Kobayashi Y, Mizuno K, Konishi A, et al. (2006) ACTH- secreting thymic carcinoid associated with multiple endocrine neoplasia type 1. Ann Thorac Surg<\/i> 81:366-368.","DOI":"10.1016\/j.athoracsur.2004.07.084"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takagi J, Otake K, Morishita M, Kato H, Nakao N, et al. (2006) Multiple endocrine neoplasia type 1 and Cushing’s syndrome due to an aggressive ACTH producing thymic carcinoid. Intern Med <\/i>45:81-86.","DOI":"10.2169\/internalmedicine.45.1427"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mizoguchi Y, Kajiume T, Miyagawa S, Okada S, Nishi Y, et al. (2007) Steroid-dependent ACTH-produced thymic carcinoid: regulation of POMC gene expression by cortisol via methylation of its promoter region. Horm Res<\/i> 67:257-262.","DOI":"10.1159\/000098548"},{"key":"17","unstructured":"17. Sato H, Kajiya H, Kanai G, Hirukawa T, Tanaka H, et al. (2010) Atypical thymic carcinoid associated with Cushing’s syndrome. Tokai J Exp Clin Med<\/i> 35:78-84."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pass HI, Doppman JL, Nieman L, Stovroff M, Vetto J, et al. (1990) Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann<\/i> Thorac Surg <\/i>50: 52-57.","DOI":"10.1016\/0003-4975(90)90085-K"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. de Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S (2002) Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome. Ann Thorac Surg <\/i>73: 675-681.","DOI":"10.1016\/S0003-4975(01)02713-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing’s syndrome. Endocr J <\/i>56: 469-476.","DOI":"10.1507\/endocrj.K08E-353"},{"key":"21","unstructured":"21. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev <\/i>19: 647-672."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sakai Y, Horiba N, Tozawa F, Sakai K, Kuwayama A, et al. (1997) Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing’s syndrome. Endocr J <\/i>44: 687-695.","DOI":"10.1507\/endocrj.44.687"},{"key":"23","unstructured":"23. Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, et al. (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constrains imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab<\/i> 87: 1646-1653."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Salgado LR, Fragoso MCBV, Knoepfelmacher M, Machado MC, Domenice S, et al. (2006) Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol <\/i>155: 725-733.","DOI":"10.1530\/eje.1.02278"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. de Keyzer Y, Lenne F, Auzan C, Jégou S, René P, et al. (1996) The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest<\/i> 97: 1311-1318.","DOI":"10.1172\/JCI118547"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ujihara M, Yoshimoto T, Cho R, Totsuka Y, Imaki T, et al. (2001) Ectopic adrenocorticotropin syndrome exhibiting paradoxical adrenocorticotropin responsiveness to gonadotropin releasing hormone. Endocr J <\/i>48: 19-23.","DOI":"10.1507\/endocrj.48.19"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Machado MC, de Sa SV, Correa-Giannella ML, Giorgi RR, Pereira MAA, et al. (2008) Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo<\/i> response to GH-releasing peptide-6 in ACTH-dependent Cushing’s syndrome patients. Eur J Endocrinol <\/i>158: 605-613.","DOI":"10.1530\/EJE-07-0659"},{"key":"28","unstructured":"28. Newell-Price J, Perry L, Medbak S, Monson J, Savage M, et al. (1997) A combined test using desmopressin and corticotrophin-releasing hormone in the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab<\/i> 82: 176-181."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Doi M, Sugiyama T, Izumiyama H, Yoshimoto T, Hirata Y (2010) Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. Endocr J <\/i>57: 1061-1069.","DOI":"10.1507\/endocrj.K10E-265"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, et al. (2004) The role of [18<\/sup>F]fluorodeoxyglucose positron emission tomography and [111<\/sup>In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab<\/i> 89: 2214-2221.","DOI":"10.1210\/jc.2003-031812"},{"key":"31","unstructured":"31. Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, et al. (1999) A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing’s disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab<\/i> 84: 487-492."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, et al.(1991) Petrosal sinus sampling with and without corticotrophin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med <\/i>325: 897-905.","DOI":"10.1056\/NEJM199109263251301"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Drury PL, Ratter S, Tomlin S, Williams J, Dacie JE, et al. (1982) Experience with selective venous sampling in diagnosis of ACTH-dependent Cushing’s syndrome. Br Med J<\/i> (Clin Res Ed)<\/i> 284:9-12.","DOI":"10.1136\/bmj.284.6308.9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinoma with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer <\/i>68: 227-232.","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I"},{"key":"35","unstructured":"35. Wick MR, Scott RE, Li CY, Carney JA (1980) Carcinoid tumor of the thymus. A clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc<\/i> 55: 246-254."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Moran CA, Suster S (2000) Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol <\/i>114: 100-110.","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Neary NM, Lopez-Chavez A, Abel BS, Boyce AM, Schaub N, et al. (2012) Neuroendocrine ACTH-producing tumor of the thymus — experience with 12 patients over 25 years. J Clin Endocrinol Metab<\/i> 97: 2223-2230.","DOI":"10.1210\/jc.2011-3355"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T04:14:42Z","timestamp":1498191282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/5\/62_EJ14-0455\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0455","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}